Outcome of Allogeneic and Autologous Hematopoietic Cell Transplant for High-Risk Peripheral T-Cell Lymphomas (PTCLs): a Retrospective Analysis From a Chinese Center

Outcome of Allogeneic and Autologous Hematopoietic Cell Transplant for High-Risk Peripheral T-Cell Lymphomas (PTCLs): a Retrospective Analysis From a Chinese Center

Highlights • This analysis showed that HCT can benefit patients with high-risk PTCL in both remission and primary refractory setting. • This analysis found that alloHCT recipients in primary refractory setting had superior OS compared with corresponding patients who received autoHCT.

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Biology of blood and marrow transplantation 2017
Hauptverfasser: Huang, Haiwen, Jiang, Yibin, Wang, Qiangli, Guo, Lingchuan, Jin, Zhengming, Fu, Zhengzheng, Han, Yue, Sun, Aining, Liu, Wei, Ruan, Jia, Wu, Depei
Format: Artikel
Sprache:eng
Schlagworte:
Hematology, Oncology and Palliative Medicine
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Highlights • This analysis showed that HCT can benefit patients with high-risk PTCL in both remission and primary refractory setting. • This analysis found that alloHCT recipients in primary refractory setting had superior OS compared with corresponding patients who received autoHCT.
ISSN:1083-8791
DOI:10.1016/j.bbmt.2017.04.021